NL7204972A - - Google Patents

Info

Publication number
NL7204972A
NL7204972A NL7204972A NL7204972A NL7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A
Authority
NL
Netherlands
Application number
NL7204972A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7204972A publication Critical patent/NL7204972A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7204972A 1971-04-21 1972-04-13 NL7204972A (enrdf_load_html_response)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13618671A 1971-04-21 1971-04-21
US13818671A 1971-04-21 1971-04-21

Publications (1)

Publication Number Publication Date
NL7204972A true NL7204972A (enrdf_load_html_response) 1972-10-24

Family

ID=26834087

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7204972A NL7204972A (enrdf_load_html_response) 1971-04-21 1972-04-13

Country Status (4)

Country Link
DE (1) DE2219408A1 (enrdf_load_html_response)
FR (1) FR2133979B1 (enrdf_load_html_response)
GB (1) GB1356763A (enrdf_load_html_response)
NL (1) NL7204972A (enrdf_load_html_response)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667300B2 (en) * 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
DK1761540T3 (en) 2004-05-13 2016-11-21 Icos Corp Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase DELTA
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
NZ611764A (en) 2008-11-13 2015-01-30 Gilead Calistoga Llc Therapies for hematologic malignancies
AU2010229968A1 (en) 2009-03-24 2011-10-13 Gilead Calistoga Llc Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
WO2010123931A1 (en) 2009-04-20 2010-10-28 Calistoga Pharmaceuticals Inc. Methods of treatment for solid tumors
WO2011011550A1 (en) 2009-07-21 2011-01-27 Calistoga Pharmaceuticals Inc. Treatment of liver disorders with pi3k inhibitors
NZ603789A (en) 2010-05-26 2015-03-27 Sunovion Pharmaceuticals Inc Heteroaryl compounds and methods of use thereof
US8765760B2 (en) * 2011-01-11 2014-07-01 Sunovion Pharmaceuticals, Inc. [1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases
CN104334560A (zh) 2012-03-05 2015-02-04 吉利德卡利斯托加有限责任公司 (s)-2-(1-(9h-嘌呤-6-基氨基)丙基)-5-氟-3-苯基喹唑啉-4(3h)-酮的多晶型物
AU2014364414A1 (en) 2013-12-20 2016-06-30 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
EP3083630B1 (en) 2013-12-20 2019-08-21 Gilead Calistoga LLC Process methods for phosphatidylinositol 3-kinase inhibitors
CA2952012A1 (en) 2014-06-13 2015-12-17 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors
CN111944340B (zh) * 2020-08-21 2022-08-05 无锡市乐卡新材料有限公司 一种耐盐雾防锈涂料

Also Published As

Publication number Publication date
GB1356763A (en) 1974-06-12
FR2133979A1 (enrdf_load_html_response) 1972-12-01
DE2219408A1 (de) 1972-10-26
FR2133979B1 (enrdf_load_html_response) 1975-10-31

Similar Documents

Publication Publication Date Title
FR2133979B1 (enrdf_load_html_response)
AU2658571A (enrdf_load_html_response)
AU2691671A (enrdf_load_html_response)
AU465401B2 (enrdf_load_html_response)
AU2564071A (enrdf_load_html_response)
AU2684071A (enrdf_load_html_response)
AU2485671A (enrdf_load_html_response)
AU3005371A (enrdf_load_html_response)
AU2952271A (enrdf_load_html_response)
AU2941471A (enrdf_load_html_response)
AU2726271A (enrdf_load_html_response)
AU2684171A (enrdf_load_html_response)
AU2654071A (enrdf_load_html_response)
AU2588771A (enrdf_load_html_response)
AU2503871A (enrdf_load_html_response)
AU2724971A (enrdf_load_html_response)
AU2930871A (enrdf_load_html_response)
AU2486471A (enrdf_load_html_response)
AU2938071A (enrdf_load_html_response)
AU2940971A (enrdf_load_html_response)
AU2577671A (enrdf_load_html_response)
AU2706571A (enrdf_load_html_response)
AU2963771A (enrdf_load_html_response)
AU2669471A (enrdf_load_html_response)
AU3025871A (enrdf_load_html_response)